cinchonine [Ligand Id: 13363] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL588619 ((8r,9s)-cinchonine, (9s)-cinchonan-9-ol, Cinchonan-9-ol, (9s)-, D-cinchonine, GNF-Pf-3189, NSC-6176, TCMDC-123933)
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364]
ChEMBL Antimicrobial activity against Plasmodium falciparum F 4.64 pIC50 23000 nM IC50 Bioorg Med Chem (2010) 18: 2225-2231 [PMID:20185316]
ChEMBL Antiplasmodial activity against Plasmodium falciparum 3D7 assessed as reduction in parasite viability by parasite lactate dehydrogenase assay F 6.53 pIC50 292.5 nM IC50 Eur J Med Chem (2015) 100: 10-17 [PMID:26063305]
ChEMBL In vitro antimalarial activity against Plasmodium falciparum W2 in human erythrocytes by [3H]hypoxanthine uptake F 6.66 pIC50 220 nM IC50 Bioorg Med Chem Lett (2002) 12: 1351-1355 [PMID:11992775]
ChEMBL Antimalarial activity against chloroquine resistant Plasmodium falciparum Dd2 after 72 hrs by SYBP Green I dye staining F 7.09 pIC50 82 nM IC50 Bioorg Med Chem (2012) 20: 3292-3297 [PMID:22512909]
ChEMBL Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 assessed as incorporation of [3H]hypoxanthine after 48 hr microdilution method F 7.25 pIC50 56 nM IC50 Med Chem Res (2007) 16: 213-229
ChEMBL In vitro inhibition of parasite development of Plasmodium falciparum W2 in human erythrocytes F 7.29 pIC50 51 nM IC50 Bioorg Med Chem Lett (2002) 12: 1351-1355 [PMID:11992775]
ChEMBL Antimalarial activity against chloroquine sensitive Plasmodium falciparum HB3 after 72 hrs by SYBP Green I dye staining F 7.66 pIC50 22 nM IC50 Bioorg Med Chem (2012) 20: 3292-3297 [PMID:22512909]
ChEMBL Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as incorporation of [3H]hypoxanthine after 48 hr microdilution method F 7.68 pIC50 21 nM IC50 Med Chem Res (2007) 16: 213-229
ChEMBL Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay F 8.3 pIC50 5 nM IC50 Antimicrob Agents Chemother (2010) 54: 3597-3604 [PMID:20547797]
ChEMBL NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay F 6.96 pEC50 110 nM EC50 Proc Natl Acad Sci U S A (2008) 105: 9059-9064 [PMID:18579783]
ChEMBL NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay F 7.02 pEC50 95.3 nM EC50 Proc Natl Acad Sci U S A (2008) 105: 9059-9064 [PMID:18579783]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]